Vincent Lotteau,Benoit De Chassey,Patrice Andre,Laurene Meyniel-Schicklin,Anne Aublin-Gex
申请号：
US14110214
公开号：
US09168236B2
申请日:
2012.04.10
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention relates to methods and pharmaceutical compositions for inhibiting influenza virus replication. More particularly, the present invention relates to a compound selected from the group consisting of Gemcitabine, Obatoclax Mesylate, Docetaxel, HA-14, Alsterpaullone, GSK3B inhibitor VIII, GSK3B inhibitor XV, Indirubin 3′-monoxime, L glutathione reduced, Fluocinolone acetonide, Tirofiban, Topotecan hydrochloride, Clofarabine, Vinblastine, Menadione Crystalline and derivatives or analogues thereof for use in the treatment of an influenza infection in a subject in need thereof.
